BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10190728)

  • 1. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.
    Albornoz L; Alvarez D; Otaso JC; Gadano A; Salviú J; Gerona S; Sorroche P; Villamil A; Mastai R
    J Hepatol; 1999 Mar; 30(3):451-5. PubMed ID: 10190728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia.
    Ferro D; Quintarelli C; Lattuada A; Leo R; Alessandroni M; Mannucci PM; Violi F
    Hepatology; 1996 Jun; 23(6):1377-83. PubMed ID: 8675154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
    Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V
    J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
    Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function.
    Yang YY; Lin HC; Lee WC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2003 Oct; 18(10):1156-61. PubMed ID: 12974902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and ascitic fluid nitrate levels in patients with cirrhosis.
    Coşkun U; Ozenirler S; Sancak B; Bukan N
    Clin Chim Acta; 2001 Apr; 306(1-2):127-32. PubMed ID: 11282103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
    Chan NN; Fuller JH; Rubens M; Colhoun HM
    Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.
    Tahan V; Avsar E; Karaca C; Uslu E; Eren F; Aydin S; Uzun H; Hamzaoglu HO; Besisik F; Kalayci C; Okten A; Tozun N
    World J Gastroenterol; 2003 Oct; 9(10):2325-7. PubMed ID: 14562402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score.
    Curakova Ristovska E; Genadieva-Dimitrova M; Caloska-Ivanova V; Misevski J
    Acta Gastroenterol Belg; 2019; 82(4):487-493. PubMed ID: 31950803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemia in rabbit.
    Haghjooyjavanmard S; Nematbakhsh M; Monajemi A; Soleimani M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):91-5. PubMed ID: 18795081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
    Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
    Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia.
    Guarner C; Soriano G; Tomas A; Bulbena O; Novella MT; Balanzo J; Vilardell F; Mourelle M; Moncada S
    Hepatology; 1993 Nov; 18(5):1139-43. PubMed ID: 8225220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Tongxinluo superfine on experimental anginal model (contraction of collaterals) in rat with endothelial dysfunction].
    Han YL; Cheng C; Tan HM; Wu WK; Wu YL; Sun HL; Sun J; Chen JL
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2404-8, 2426. PubMed ID: 18257270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.
    Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G
    J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis.
    Curgunlu A; Vural P; Canbaz M; Erten N; Karan MA; Tascioglu C
    J Clin Lab Anal; 2005; 19(5):177-81. PubMed ID: 16170811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.